1-2 of 2
Jonathan S. Lewin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Suppression of Prostate Carcinogenesis by Dietary Supplementation of Celecoxib in Transgenic Adenocarcinoma of the Mouse Prostate Model

Free
Sanjay Gupta, Vaqar M. Adhami, Murugesan Subbarayan, Gregory T. MacLennan, Jonathan S. Lewin, Urs O. Hafeli, Pingfu Fu, Hasan Mukhtar
Journal: Cancer Research
Cancer Res (2004) 64 (9): 3334–3343.
https://doi.org/10.1158/0008-5472.CAN-03-2422
Published: 03 May 2004
View articletitled, Suppression of Prostate Carcinogenesis by Dietary Supplementation of Celecoxib in Transgenic Adenocarcinoma of the Mouse Prostate Model
Open the PDF for Suppression of Prostate Carcinogenesis by Dietary Supplementation of Celecoxib in Transgenic Adenocarcinoma of the Mouse Prostate Model in another window
Journal Articles

A Phase I Pharmacokinetic and Translational Study of the Novel Vascular Targeting Agent Combretastatin A-4 Phosphate on a Single-Dose Intravenous Schedule in Patients with Advanced Cancer

Free
Afshin Dowlati, Kelly Robertson, Matthew Cooney, William P. Petros, Michael Stratford, John Jesberger, Niusha Rafie, Beth Overmoyer, Vinit Makkar, Bruce Stambler, Anne Taylor, John Waas, Jonathan S. Lewin, Keith R. McCrae, Scot C. Remick
Journal: Cancer Research
Cancer Res (2002) 62 (12): 3408–3416.
Published: 01 June 2002
View articletitled, A Phase I Pharmacokinetic and Translational Study of the Novel Vascular Targeting Agent Combretastatin A-4 Phosphate on a Single-Dose Intravenous Schedule in Patients with Advanced Cancer
Open the PDF for A Phase I Pharmacokinetic and Translational Study of the Novel Vascular Targeting Agent Combretastatin A-4 Phosphate on a Single-Dose Intravenous Schedule in Patients with Advanced Cancer in another window